Clinicopathological analysis of ovarian pseudomyxoma peritonei
10.3969/j.issn.1000-8179.2019.17.584
- VernacularTitle:卵巢来源腹膜假黏液瘤临床病理分析*
- Author:
Fengcai YAN
1
;
Xinbao LI
;
Yulin LIN
;
Chunkai YU
;
Quan ZHOU
;
Yan LI
Author Information
1. 首都医科大学附属北京世纪坛医院病理科(北京市100038)
- Keywords:
ovary;
pseudomyxoma peritonei (PMP);
clinicopathology;
immunohistochemistry
- From:
Chinese Journal of Clinical Oncology
2019;46(17):887-890
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To analyze the clinicopathological characteristics of ovarian pseudomyxoma peritonei (PMP). Methods: Clinical and pathological data from a total of 272 PMP patients diagnosed at Beijing Shijitan Hospital from January 2010 to January 2019 were collected from a database and retrospectively analyzed to study the origin of PMP tumors. Pathological slides marked with antigens were further studied using immunohistochemical staining, including CK7, CK20, CEA, Villin, CDX2, SATB2, CA125, ER, PR, MUC1, and MUC2. Results: Among the 272 PMP patients studied, the tumors of 245 (90.1%) originated from the appendix, while the remaining 27 (9.9%) originated from non-appendix tissues, including 5 (1.8%) from the ovaries. Ovarian cases included two ovarian teratomas, two ovarian mucinous cystadenomas, and one borderline ovarian mucinous cystadenoma. Histopathological analysis of peritoneal me-tastases further revealed two acellular mucins, two low-grade mucinous carcinoma peritonei, and one high-grade mucinous carcinoma peritonei, while immunohistochemistry revealed positive staining for CK20, CEA, Villin, and CDX2; SATB2 was also found to be partially positive in teratomas with mucinous tumors: negative in two cases and partially positive in one case. Conclusions: The occurrence of ovarian PMP is rare. Its precise diagnosis demands for a serial section of the whole appendix or suspected tissue to exclude any appen-diceal mucinous neoplasms, as well as the combination of a comprehensive analysis of its clinical signs and symptoms, imaging find-ings, surgical findings, histopathological characteristics, and immunohistochemistry.
